Joshua T. Brumm, Chief Executive Officer at CRESCENT BIOPHARMA, INC. (CBIO), sold 42,305 shares at $17.99 ($761K) on 2026-06-22, disclosed to the SEC on 2026-06-23.
Scheduled sale ($761k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| DYN | SELL | 2024-03-11 | $470K | — | Filing → |
| DYN | SELL | 2024-03-01 | $5.1M | — | Filing → |
| DYN | SELL | 2024-01-04 | $9.7M | — | Filing → |